BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 17119052)

  • 1. Polymorphisms of vitamin D receptor and survival in early-stage non-small cell lung cancer patients.
    Zhou W; Heist RS; Liu G; Neuberg DS; Asomaning K; Su L; Wain JC; Lynch TJ; Giovannucci E; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2239-45. PubMed ID: 17119052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VEGF polymorphisms and survival in early-stage non-small-cell lung cancer.
    Heist RS; Zhai R; Liu G; Zhou W; Lin X; Su L; Asomaning K; Lynch TJ; Wain JC; Christiani DC
    J Clin Oncol; 2008 Feb; 26(6):856-62. PubMed ID: 18281657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D is associated with improved survival in early-stage non-small cell lung cancer patients.
    Zhou W; Suk R; Liu G; Park S; Neuberg DS; Wain JC; Lynch TJ; Giovannucci E; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2303-9. PubMed ID: 16214909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smoking cessation before diagnosis and survival in early stage non-small cell lung cancer patients.
    Zhou W; Heist RS; Liu G; Park S; Neuberg DS; Asomaning K; Wain JC; Lynch TJ; Christiani DC
    Lung Cancer; 2006 Sep; 53(3):375-80. PubMed ID: 16814423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in the CASPASE genes and survival in patients with early-stage non-small-cell lung cancer.
    Yoo SS; Choi JE; Lee WK; Choi YY; Kam S; Kim MJ; Jeon HS; Lee EB; Kim DS; Lee MH; Kim IS; Jheon S; Park JY
    J Clin Oncol; 2009 Dec; 27(34):5823-9. PubMed ID: 19826114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer.
    Park JY; Lee WK; Jung DK; Choi JE; Park TI; Lee EB; Cho S; Park JY; Cha SI; Kim CH; Kam S; Jung TH; Jheon S
    Clin Cancer Res; 2009 Mar; 15(5):1794-800. PubMed ID: 19240174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinase polymorphisms and survival in stage I non-small cell lung cancer.
    Heist RS; Marshall AL; Liu G; Zhou W; Su L; Neuberg D; Lynch TJ; Wain J; Christiani DC
    Clin Cancer Res; 2006 Sep; 12(18):5448-53. PubMed ID: 17000679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating 25-hydroxyvitamin D, VDR polymorphisms, and survival in advanced non-small-cell lung cancer.
    Heist RS; Zhou W; Wang Z; Liu G; Neuberg D; Su L; Asomaning K; Hollis BW; Lynch TJ; Wain JC; Giovannucci E; Christiani DC
    J Clin Oncol; 2008 Dec; 26(34):5596-602. PubMed ID: 18936471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of germ line polymorphisms of the CYP1A1 and glutathione S-transferase genes in patients with non-small cell lung cancer.
    Goto I; Yoneda S; Yamamoto M; Kawajiri K
    Cancer Res; 1996 Aug; 56(16):3725-30. PubMed ID: 8706015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second hand smoke exposure and survival in early-stage non-small-cell lung cancer patients.
    Zhou W; Heist RS; Liu G; Asomaning K; Miller DP; Neuberg DS; Wain JC; Lynch TJ; Christiani DC
    Clin Cancer Res; 2006 Dec; 12(23):7187-93. PubMed ID: 17145845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclooxygenase-2 genetic variants are associated with survival in unresectable locally advanced non-small cell lung cancer.
    Bi N; Yang M; Zhang L; Chen X; Ji W; Ou G; Lin D; Wang L
    Clin Cancer Res; 2010 Apr; 16(8):2383-90. PubMed ID: 20332326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role?
    Porojnicu AC; Robsahm TE; Dahlback A; Berg JP; Christiani D; Bruland OS; Moan J
    Lung Cancer; 2007 Mar; 55(3):263-70. PubMed ID: 17207891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between glutathione S-transferase pi polymorphisms and survival in patients with advanced nonsmall cell lung carcinoma.
    Lu C; Spitz MR; Zhao H; Dong Q; Truong M; Chang JY; Blumenschein GR; Hong WK; Wu X
    Cancer; 2006 Jan; 106(2):441-7. PubMed ID: 16342067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis.
    El-Sherif A; Gooding WE; Santos R; Pettiford B; Ferson PF; Fernando HC; Urda SJ; Luketich JD; Landreneau RJ
    Ann Thorac Surg; 2006 Aug; 82(2):408-15; discussion 415-6. PubMed ID: 16863738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy.
    Zhou W; Gurubhagavatula S; Liu G; Park S; Neuberg DS; Wain JC; Lynch TJ; Su L; Christiani DC
    Clin Cancer Res; 2004 Aug; 10(15):4939-43. PubMed ID: 15297394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of ERCC2 haplotype-tagging single nucleotide polymorphisms in patients with unresectable non-small cell lung cancer treated with first-line platinum-based chemotherapy.
    Kim SH; Lee GW; Lee MJ; Cho YJ; Jeong YY; Kim HC; Lee JD; Hwang YS; Kim IS; Lee S; Oh SY
    Lung Cancer; 2012 Sep; 77(3):578-84. PubMed ID: 22608006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective assessment of XPD Lys751Gln and XRCC1 Arg399Gln single nucleotide polymorphisms in lung cancer.
    Giachino DF; Ghio P; Regazzoni S; Mandrile G; Novello S; Selvaggi G; Gregori D; DeMarchi M; Scagliotti GV
    Clin Cancer Res; 2007 May; 13(10):2876-81. PubMed ID: 17504986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D receptor gene polymorphisms and epithelial ovarian cancer risk.
    Lurie G; Wilkens LR; Thompson PJ; McDuffie KE; Carney ME; Terada KY; Goodman MT
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2566-71. PubMed ID: 18086759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor receptor 2 gene polymorphisms as predictors for tumor recurrence and overall survival in non-small-cell lung cancer.
    Uzunoglu FG; Kaufmann C; Wikman H; Güngör C; Bohn BA; Nentwich MF; Reeh M; Pantel K; Bockhorn M; Kutup A; Mann O; Izbicki JR; Vashist YK
    Ann Surg Oncol; 2012 Jul; 19(7):2159-68. PubMed ID: 22395975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms in EGFR and VEGF contribute to non-small-cell lung cancer survival in a Chinese population.
    Dong J; Dai J; Shu Y; Pan S; Xu L; Chen W; Wang Y; Jin G; Ma H; Zhang M; Hu Z; Shen H
    Carcinogenesis; 2010 Jun; 31(6):1080-6. PubMed ID: 20400478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.